drug · antibody
bafisontamab
Phase 2updated 3mo agoby EpimAb Biotherapeutics Inc🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 1 2 (across all indications), with 2 investigational indications.
indications
indications
NSCLC
targets
Epidermal growth factor receptorHepatocyte growth factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 43m ago
Found something off?
comments(0)
5-min edit window · permanent after that